FT Conferences, London Marriott Hotel, Grosvenor Square, London
03 & 04 October, 2005
This high-level industry conference is a must-attend for pharmaceutical and biotechnology firms, investors and industry analysts. Through a series of lively panel debates and expert analysis, leading industry speakers from across the globe will explore the strategic opportunities and initiatives to overcome the significant challenges facing the industry.
|
|
|
Invited Speakers:
|
|
Dr Lester M. Crawford, D.V.M.,
Commissioner of Food and Drugs, FDASir David Cooksey,
Chairman, Advent Venture Partners Mr Peter Chambr?
Chief Executive Officer, Cambridge Antibody Technology Dr Peter B Corr,
Senior Vice President, Science and Technology, Pfizer Inc Dr Roch Doliveux,
Chief Executive Officer, UCB-Group Prof Klaus Lindpaintner,
Director, Roche Centre for Medical Genomics, F. Hoffman-La Roche Ltd Mr Mark Levin,
CEO, Millennium Pharmaceuticals, Inc Dr Duncan Moore,
Managing Director & Global Team Leader, Morgan Stanley Mr Simon Sturge,
CEO, Vernalis plc
|
|